A comprehensive view of Complete Response Letters (CRL) / Disapproval. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA denies approval for Viatris and Mapi Pharma's monthly multiple sclerosis injection GA Depot; Viatris confirms decision will not impact future revenue or new product range

FDA rejects Eli Lilly's eczema treatment lebrikizumab due to issues found during inspection at third-party contract manufacturing organization; FDA has rejected three Lilly drugs this year

Regeneron suffers set-back for release of new version of high-dose Eylea eye-medicine after FDA rejects approval request due to manufacturing issue; FDA raises no safety or efficiency issues, or demand for new trials

FDA rejects Eli Lilly's ulcerative colitis drug mirikizumab due to manufacturing issues; approval in Japan and ongoing review in Europe remain intact

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count